Up-regulation of Bfl-1/A1 via NF-κB activation in cisplatin-resistant human bladder cancer cell line

This publication has 28 references indexed in Scilit:

• Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition
  Oncogene, 2000
• Structural Basis of BFL-1 for Its Interaction with BAX and Its Anti-apoptotic Action in Mammalian and Yeast Cells
  Published by Elsevier ,2000
• The CD40-Inducible Bcl-2 Family Member A1 Protects B Cells from Antigen Receptor-Mediated Apoptosis
  Cellular Immunology, 2000
• Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli
  Oncogene, 1999
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosis
  Genes & Development, 1999
• A1 Is a Constitutive and Inducible Bcl-2 Homologue in Mature Human Neutrophils
  Biochemical and Biophysical Research Communications, 1998
• Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer
  Oncogene, 1998
• Mycobacterium bovis Bacillus Calmette Guérin infection prevents apoptosis of resting human monocytes
  European Journal of Immunology, 1997
• Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
  Journal of Clinical Investigation, 1991
• Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
  Biochemistry, 1988